Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease

Background and aims Subjects with congenital chloride diarrhea (CLD; a defect in solute carrier family 26 member 3 (SLC26A3)) are prone to inflammatory bowel disease (IBD). We investigated fecal microbiota in CLD and CLD-associated IBD. We also tested whether microbiota is modulated by supplementation with the short-chain fatty acid butyrate. Subjects and methods We recruited 30 patients with CLD for an observational 3-week follow-up study. Thereafter, 16 consented to oral butyrate substitution for a 3-week observational period. Fecal samples, collected once a week, were assayed for calprotectin and potential markers of inflammation, and studied by 16S ribosomal ribonucleic acid (rRNA) gene amplicon sequencing and compared to that of 19 healthy controls and 43 controls with Crohn’s disease. Data on intestinal symptoms, diet and quality of life were collected. Results Patients with CLD had increased abundances of Proteobacteria, Veillonella, and Prevotella, and lower abundances of normally dominant taxa Ruminococcaceae and Lachnospiraceae when compared with healthy controls and Crohn´s disease. No major differences in fecal microbiota were found between CLD and CLD-associated IBD (including two with yet untreated IBD). Butyrate was poorly tolerated and showed no major effects on fecal microbiota or biomarkers in CLD. Conclusions Fecal microbiota in CLD is different from that of healthy subjects or Crohn´s disease. Unexpectedly, no changes in the microbiota or fecal markers characterized CLD-associated IBD, an entity with high frequency among patients with CLD.

Saved in:
Bibliographic Details
Main Authors: Wedenoja, Satu, Saarikivi, Aki, Mälkönen, Jani, Leskinen, Saara, Lehto, Markku, Adeshara, Krishna, Tuokkola, Jetta, Nikkonen, Anne, Merras-Salmio, Laura, Höyhtyä, Miikka, Hörkkö, Sohvi, Haaramo, Anu, Salonen, Anne, de Vos, Willem M., Korpela, Katri, Kolho, Kaija Leena
Format: Article/Letter to editor biblioteca
Language:English
Subjects:Life Science,
Online Access:https://research.wur.nl/en/publications/fecal-microbiota-in-congenital-chloride-diarrhea-and-inflammatory
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-wur-nl-wurpubs-598760
record_format koha
spelling dig-wur-nl-wurpubs-5987602025-01-14 Wedenoja, Satu Saarikivi, Aki Mälkönen, Jani Leskinen, Saara Lehto, Markku Adeshara, Krishna Tuokkola, Jetta Nikkonen, Anne Merras-Salmio, Laura Höyhtyä, Miikka Hörkkö, Sohvi Haaramo, Anu Salonen, Anne de Vos, Willem M. Korpela, Katri Kolho, Kaija Leena Article/Letter to editor PLoS ONE 17 (2022) 6 June ISSN: 1932-6203 Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease 2022 Background and aims Subjects with congenital chloride diarrhea (CLD; a defect in solute carrier family 26 member 3 (SLC26A3)) are prone to inflammatory bowel disease (IBD). We investigated fecal microbiota in CLD and CLD-associated IBD. We also tested whether microbiota is modulated by supplementation with the short-chain fatty acid butyrate. Subjects and methods We recruited 30 patients with CLD for an observational 3-week follow-up study. Thereafter, 16 consented to oral butyrate substitution for a 3-week observational period. Fecal samples, collected once a week, were assayed for calprotectin and potential markers of inflammation, and studied by 16S ribosomal ribonucleic acid (rRNA) gene amplicon sequencing and compared to that of 19 healthy controls and 43 controls with Crohn’s disease. Data on intestinal symptoms, diet and quality of life were collected. Results Patients with CLD had increased abundances of Proteobacteria, Veillonella, and Prevotella, and lower abundances of normally dominant taxa Ruminococcaceae and Lachnospiraceae when compared with healthy controls and Crohn´s disease. No major differences in fecal microbiota were found between CLD and CLD-associated IBD (including two with yet untreated IBD). Butyrate was poorly tolerated and showed no major effects on fecal microbiota or biomarkers in CLD. Conclusions Fecal microbiota in CLD is different from that of healthy subjects or Crohn´s disease. Unexpectedly, no changes in the microbiota or fecal markers characterized CLD-associated IBD, an entity with high frequency among patients with CLD. en application/pdf https://research.wur.nl/en/publications/fecal-microbiota-in-congenital-chloride-diarrhea-and-inflammatory 10.1371/journal.pone.0269561 https://edepot.wur.nl/572216 Life Science https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/ Wageningen University & Research
institution WUR NL
collection DSpace
country Países bajos
countrycode NL
component Bibliográfico
access En linea
databasecode dig-wur-nl
tag biblioteca
region Europa del Oeste
libraryname WUR Library Netherlands
language English
topic Life Science
Life Science
spellingShingle Life Science
Life Science
Wedenoja, Satu
Saarikivi, Aki
Mälkönen, Jani
Leskinen, Saara
Lehto, Markku
Adeshara, Krishna
Tuokkola, Jetta
Nikkonen, Anne
Merras-Salmio, Laura
Höyhtyä, Miikka
Hörkkö, Sohvi
Haaramo, Anu
Salonen, Anne
de Vos, Willem M.
Korpela, Katri
Kolho, Kaija Leena
Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease
description Background and aims Subjects with congenital chloride diarrhea (CLD; a defect in solute carrier family 26 member 3 (SLC26A3)) are prone to inflammatory bowel disease (IBD). We investigated fecal microbiota in CLD and CLD-associated IBD. We also tested whether microbiota is modulated by supplementation with the short-chain fatty acid butyrate. Subjects and methods We recruited 30 patients with CLD for an observational 3-week follow-up study. Thereafter, 16 consented to oral butyrate substitution for a 3-week observational period. Fecal samples, collected once a week, were assayed for calprotectin and potential markers of inflammation, and studied by 16S ribosomal ribonucleic acid (rRNA) gene amplicon sequencing and compared to that of 19 healthy controls and 43 controls with Crohn’s disease. Data on intestinal symptoms, diet and quality of life were collected. Results Patients with CLD had increased abundances of Proteobacteria, Veillonella, and Prevotella, and lower abundances of normally dominant taxa Ruminococcaceae and Lachnospiraceae when compared with healthy controls and Crohn´s disease. No major differences in fecal microbiota were found between CLD and CLD-associated IBD (including two with yet untreated IBD). Butyrate was poorly tolerated and showed no major effects on fecal microbiota or biomarkers in CLD. Conclusions Fecal microbiota in CLD is different from that of healthy subjects or Crohn´s disease. Unexpectedly, no changes in the microbiota or fecal markers characterized CLD-associated IBD, an entity with high frequency among patients with CLD.
format Article/Letter to editor
topic_facet Life Science
author Wedenoja, Satu
Saarikivi, Aki
Mälkönen, Jani
Leskinen, Saara
Lehto, Markku
Adeshara, Krishna
Tuokkola, Jetta
Nikkonen, Anne
Merras-Salmio, Laura
Höyhtyä, Miikka
Hörkkö, Sohvi
Haaramo, Anu
Salonen, Anne
de Vos, Willem M.
Korpela, Katri
Kolho, Kaija Leena
author_facet Wedenoja, Satu
Saarikivi, Aki
Mälkönen, Jani
Leskinen, Saara
Lehto, Markku
Adeshara, Krishna
Tuokkola, Jetta
Nikkonen, Anne
Merras-Salmio, Laura
Höyhtyä, Miikka
Hörkkö, Sohvi
Haaramo, Anu
Salonen, Anne
de Vos, Willem M.
Korpela, Katri
Kolho, Kaija Leena
author_sort Wedenoja, Satu
title Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease
title_short Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease
title_full Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease
title_fullStr Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease
title_full_unstemmed Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease
title_sort fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease
url https://research.wur.nl/en/publications/fecal-microbiota-in-congenital-chloride-diarrhea-and-inflammatory
work_keys_str_mv AT wedenojasatu fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT saarikiviaki fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT malkonenjani fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT leskinensaara fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT lehtomarkku fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT adesharakrishna fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT tuokkolajetta fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT nikkonenanne fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT merrassalmiolaura fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT hoyhtyamiikka fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT horkkosohvi fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT haaramoanu fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT salonenanne fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT devoswillemm fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT korpelakatri fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
AT kolhokaijaleena fecalmicrobiotaincongenitalchloridediarrheaandinflammatoryboweldisease
_version_ 1822265369416433664